📊 AFYA Key Takeaways
Is Afya Ltd (AFYA) a Good Investment?
Unable to conduct meaningful fundamental analysis due to complete absence of financial data from SEC filings. Company shows no available income statement, balance sheet, or cash flow metrics. Insufficient data to assess profitability, financial health, or growth quality.
Afya’s fundamentals are strong, with double-digit revenue growth, expanding adjusted EBITDA, rising net income, and excellent cash generation in its latest SEC-reported results. Financial health also improved as cash increased and net leverage declined, indicating that growth is being supported by solid operating performance rather than balance-sheet strain. The main constraint on a more aggressive rating is execution risk around acquisitions, regulation, and softer engagement trends in parts of the digital solutions business.
Why Buy Afya Ltd Stock? AFYA Key Strengths
- Listed on Nasdaq exchange
- Educational services sector with potential for recurring revenue models
- Revenue grew 11.9% in FY2025, with 9.2% organic growth excluding acquisitions, showing solid underlying demand
- Profitability remains high, with adjusted EBITDA margin of 45.4% and net income up 18.4% year over year
- Cash generation and balance-sheet quality improved, with operating cash flow of about R$1.55 billion, free cash flow of R$1.06 billion, and net debt to adjusted EBITDA of 0.8x excluding IFRS 16
AFYA Stock Risks: Afya Ltd Investment Risks
- Critical lack of available financial data preventing analysis
- No revenue, income, or asset information disclosed
- Inability to assess solvency, liquidity, or operational efficiency
- Zero insider activity reported in last 90 days suggesting limited confidence signaling
- Business is concentrated in Brazilian medical education and depends on regulatory approvals for seats and campus expansion
- Acquisition-driven growth adds integration risk and can obscure true underlying performance if execution weakens
- Medical Practice Solutions showed weaker user trends, including declining monthly active users and pressure in some B2B lines
Key Metrics to Watch
- Revenue and revenue growth trends
- Net income and operating margins
- Free cash flow generation
- Balance sheet strength and debt levels
- Return on equity and return on assets
- Organic revenue growth excluding acquisitions across undergraduate and digital segments
- Net debt to adjusted EBITDA and sustained free cash flow conversion
Afya Ltd (AFYA) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
AFYA Profit Margin, ROE & Profitability Analysis
AFYA vs Services Sector: How Afya Ltd Compares
How Afya Ltd compares to Services sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Afya Ltd Stock Overvalued? AFYA Valuation Analysis 2026
Based on fundamental analysis, Afya Ltd has mixed fundamental signals relative to the Services sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Afya Ltd Balance Sheet: AFYA Debt, Cash & Liquidity
AFYA Revenue Growth, EPS Growth & YoY Performance
AFYA SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Afya Ltd (CIK: 0001771007)
📋 Recent SEC Filings
❓ Frequently Asked Questions about AFYA
What is the AI rating for AFYA?
Afya Ltd (AFYA) has a Combined AI Rating of BUY from Claude (HOLD) and ChatGPT (BUY) with 43% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are AFYA's key strengths?
Claude: Listed on Nasdaq exchange. Educational services sector with potential for recurring revenue models. ChatGPT: Revenue grew 11.9% in FY2025, with 9.2% organic growth excluding acquisitions, showing solid underlying demand. Profitability remains high, with adjusted EBITDA margin of 45.4% and net income up 18.4% year over year.
What are the risks of investing in AFYA?
Claude: Critical lack of available financial data preventing analysis. No revenue, income, or asset information disclosed. ChatGPT: Business is concentrated in Brazilian medical education and depends on regulatory approvals for seats and campus expansion. Acquisition-driven growth adds integration risk and can obscure true underlying performance if execution weakens.
What is AFYA's revenue and growth?
Afya Ltd reported revenue of N/A.
Does AFYA pay dividends?
Afya Ltd does not currently pay dividends.
Where can I find AFYA SEC filings?
Official SEC filings for Afya Ltd (CIK: 0001771007) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is AFYA's EPS?
Afya Ltd has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is AFYA a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Afya Ltd has a BUY rating with 43% confidence. The AI analysis suggests favorable fundamentals based on SEC filings. This is not investment advice.
Is AFYA stock overvalued or undervalued?
Valuation metrics for AFYA: ROE of N/A (sector avg: 16%), net margin of N/A (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy AFYA stock in 2026?
Our dual AI analysis gives Afya Ltd a combined BUY rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is AFYA's free cash flow?
Afya Ltd's operating cash flow is N/A, with capital expenditures of N/A.
How does AFYA compare to other Services stocks?
Vs Services sector averages: Net margin N/A (avg: 10%), ROE N/A (avg: 16%), current ratio N/A (avg: 1.5).